HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
Joan Llevadot(Hospital Clínic de Barcelona), Takayuki Asahara(Shonan Kamakura General Hospital)
Cited by 651
Related Papers
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
|Journal of Clinical Investigation|1999|770
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
|Journal of Clinical Investigation|2001|609